As regards Article 168(4)(c) TFEU, this Regulation sets high standards of quality and safety for in vitro diagnostic medical devices by ensuring, among other things, that data generated in performance studies are reliable and robust and that the safety of subjects participating in performance studies is protected.
Maidir le hAirteagal 168(4)(c) CFAE, socraítear leis an Rialachán seo ardchaighdeáin cháilíochta agus sábháilteachta d'fheistí leighis diagnóiseacha in vitro trína áirithiú, inter alia, go mbeidh na sonraí arna nginiúint trí staidéir feidhmíochta intaofa agus láidir agus go gcosnófar sábháilteacht na n-ábhar atá rannpháirteach i staidéir feidhmíochta.